Schrödinger Appoints Professor Brian Shoichet to Scientific Advisory Board
Summary
NEW YORK--( BUSINESS WIRE )-- Schrödinger today announced the appointment of Professor of Chemistry Brian Shoichet, Ph.D., a widely published thought leader in the field of computational drug discovery, to its scientific advisory board (SAB). “I am thrilled to join the exceptional team at Schrödinger in support of our shared mission to open new possibilities for drug discovery by continuing to advance the field of computational modeling,” said Professor Shoichet. He currently serves in the Department of Pharmaceutical Chemistry at the University of California, San Francisco, where his lab combines computational modeling with detailed experimental testing and applies the resulting methods to new chemotype discovery. “I am specifically interested in focusing on how FEP+ can improve workflows during early compound optimization for hits selected from large library docking screens,” Professor Shoichet added. Schrödinger has a substantial and growing global business, licensing its industry-leading computational platform to pharmaceutical, biotechnology, chemical, and electronics companies to accelerate R&D in both drug discovery and materials design.
Classifications
AskAI Classifications
LabelsLinked Companies
